Total number of protein in "GO:0032689" GO term: 42
Identifier | UniProt Gene | UniProt Accession | UniProt Name | Chromosome | GO term | Database | Cancer Driver | Number of missense mutations | Missense mutation per residues | Number of disordered residues | Number of mutations in disordered regions | Disordered missense mutations per residues | Number of OMIM mutation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AXL-201 | AXL | P30530 | Tyrosine-protein kinase receptor UFO | chr19 | GO:0032689 | Not Cancer Driver | No | 131 | 0.1465324384787472 | 342 | 51 | 0.0570469798657718 | 0 |
C1QBP-201 | C1QBP | Q07021 | Complement component 1 Q subcomponent-binding protein, mitochondrial | chr17 | GO:0032689 | Not Cancer Driver | No | 14 | 0.0496453900709219 | 103 | 5 | 0.0177304964539007 | 2 |
CD274-202 | CD274 | Q9NZQ7 | Programmed cell death 1 ligand 1 | chr9 | GO:0032689 | Census | Yes | 26 | 0.0896551724137931 | 54 | 9 | 0.0310344827586206 | 0 |
CD96-201 | CD96 | P40200 | T-cell surface protein tactile | chr3 | GO:0032689 | Not Cancer Driver | No | 104 | 0.1777777777777777 | 165 | 28 | 0.0478632478632478 | 1 |
CR1-206 | CR1 | P17927 | Complement receptor type 1 | chr1 | GO:0032689 | Compendium | Yes | 273 | 0.1338891613536047 | 153 | 28 | 0.0137322216772927 | 0 |
DDIT3-201 | DDIT3 | P35638 | DNA damage-inducible transcript 3 protein | chr12 | GO:0032689 | Census | Yes | 19 | 0.1124260355029585 | 161 | 17 | 0.1005917159763313 | 0 |
FOXP3-203 | FOXP3 | Q9BZS1 | Forkhead box protein P3 | chrX | GO:0032689 | Not Cancer Driver | No | 29 | 0.0672853828306264 | 186 | 13 | 0.0301624129930394 | 10 |
GAS6-201 | GAS6 | Q14393 | Growth arrest-specific protein 6 | chr13 | GO:0032689 | Not Cancer Driver | No | 60 | 0.0884955752212389 | 43 | 3 | 0.0044247787610619 | 0 |
GATA3-201 | GATA3 | P23771 | Trans-acting T-cell-specific transcription factor GATA-3 | chr10 | GO:0032689 | Census, Compendium | Yes | 99 | 0.2234762979683973 | 368 | 79 | 0.1783295711060948 | 2 |
HAVCR2-201 | HAVCR2 | Q8TDQ0 | Hepatitis A virus cellular receptor 2 | chr5 | GO:0032689 | Not Cancer Driver | No | 45 | 0.1495016611295681 | 17 | 1 | 0.0033222591362126 | 3 |
HLA-DRB1-201 | HLA-DRB1 | P01911 | HLA class II histocompatibility antigen, DRB1 beta chain | chr6 | GO:0032689 | Not Cancer Driver | No | 11 | 0.0413533834586466 | 12 | 0 | 0.0 | 0 |
HMGB1-203 | HMGB1 | P09429 | High mobility group protein B1 | chr13 | GO:0032689 | Not Cancer Driver | No | 10 | 0.0465116279069767 | 202 | 7 | 0.0325581395348837 | 0 |
IL10-202 | IL10 | P22301 | Interleukin-10 | chr1 | GO:0032689 | Not Cancer Driver | No | 17 | 0.095505617977528 | 23 | 1 | 0.0056179775280898 | 0 |
IL1RL1-201 | IL1RL1 | Q01638 | Interleukin-1 receptor-like 1 | chr2 | GO:0032689 | Not Cancer Driver | No | 101 | 0.1816546762589928 | 25 | 5 | 0.0089928057553956 | 0 |
IL20RB-201 | IL20RB | Q6UXL0 | Interleukin-20 receptor subunit beta | chr3 | GO:0032689 | Not Cancer Driver | No | 31 | 0.0996784565916398 | 0 | 0 | 0.0 | 0 |
IL33-206 | IL33 | O95760 | Interleukin-33 | chr9 | GO:0032689 | Not Cancer Driver | No | 31 | 0.1148148148148148 | 47 | 5 | 0.0185185185185185 | 0 |
IL36RN-202 | IL36RN | Q9UBH0 | Interleukin-36 receptor antagonist protein | chr2 | GO:0032689 | Not Cancer Driver | No | 27 | 0.1741935483870967 | 7 | 2 | 0.0129032258064516 | 4 |
INHA-201 | INHA | P05111 | Inhibin alpha chain | chr2 | GO:0032689 | Not Cancer Driver | No | 43 | 0.1174863387978142 | 144 | 13 | 0.0355191256830601 | 0 |
INHBA-201 | INHBA | P08476 | Inhibin beta A chain | chr7 | GO:0032689 | Not Cancer Driver | No | 121 | 0.284037558685446 | 154 | 54 | 0.1267605633802817 | 0 |
IRGM-202 | IRGM | A1A4Y4 | Immunity-related GTPase family M protein | chr5 | GO:0032689 | Not Cancer Driver | No | 7 | 0.0386740331491712 | 51 | 0 | 0.0 | 0 |
LAPTM5-201 | LAPTM5 | Q13571 | Lysosomal-associated transmembrane protein 5 | chr1 | GO:0032689 | Not Cancer Driver | No | 34 | 0.1297709923664122 | 16 | 4 | 0.015267175572519 | 0 |
LGALS9-203 | LGALS9 | O00182 | Galectin-9 | chr17 | GO:0032689 | Not Cancer Driver | No | 46 | 0.1295774647887324 | 65 | 13 | 0.0366197183098591 | 0 |
LGALS9B-202 | LGALS9B | Q3B8N2 | Galectin-9B | chr17 | GO:0032689 | Not Cancer Driver | No | 34 | 0.095505617977528 | 87 | 17 | 0.047752808988764 | 0 |
LGALS9C-201 | LGALS9C | Q6DKI2 | Galectin-9C | chr17 | GO:0032689 | Not Cancer Driver | No | 24 | 0.0674157303370786 | 80 | 6 | 0.0168539325842696 | 0 |
LILRB1-201 | LILRB1 | Q8NHL6 | Leukocyte immunoglobulin-like receptor subfamily B member 1 | chr19 | GO:0032689 | Not Cancer Driver | No | 170 | 0.2607361963190184 | 325 | 86 | 0.1319018404907975 | 0 |
LILRB4-211 | LILRB4 | Q8NHJ6 | Leukocyte immunoglobulin-like receptor subfamily B member 4 | chr19 | GO:0032689 | Not Cancer Driver | No | 122 | 0.2723214285714285 | 276 | 88 | 0.1964285714285714 | 0 |
NLRP6-201 | NLRP6 | P59044 | NACHT, LRR and PYD domains-containing protein 6 | chr11 | GO:0032689 | Not Cancer Driver | No | 68 | 0.0762331838565022 | 205 | 11 | 0.0123318385650224 | 0 |
NOD2-201 | NOD2 | Q9HC29 | Nucleotide-binding oligomerization domain-containing protein 2 | chr16 | GO:0032689 | Not Cancer Driver | No | 130 | 0.125 | 41 | 3 | 0.0028846153846153 | 15 |
NR1H4-209 | NR1H4 | Q96RI1 | Bile acid receptor | chr12 | GO:0032689 | Not Cancer Driver | No | 82 | 0.1687242798353909 | 78 | 13 | 0.0267489711934156 | 0 |
PDCD1LG2-201 | PDCD1LG2 | Q9BQ51 | Programmed cell death 1 ligand 2 | chr9 | GO:0032689 | Census, Compendium | Yes | 26 | 0.0952380952380952 | 42 | 8 | 0.0293040293040293 | 0 |
PGLYRP1-201 | PGLYRP1 | O75594 | Peptidoglycan recognition protein 1 | chr19 | GO:0032689 | Not Cancer Driver | No | 27 | 0.1377551020408163 | 4 | 0 | 0.0 | 0 |
PGLYRP2-202 | PGLYRP2 | Q96PD5 | N-acetylmuramoyl-L-alanine amidase | chr19 | GO:0032689 | Not Cancer Driver | No | 82 | 0.1423611111111111 | 163 | 22 | 0.0381944444444444 | 0 |
PGLYRP3-202 | PGLYRP3 | Q96LB9 | Peptidoglycan recognition protein 3 | chr1 | GO:0032689 | Not Cancer Driver | No | 64 | 0.187683284457478 | 0 | 0 | 0.0 | 0 |
PRNP-201 | PRNP | P04156 | Major prion protein | chr20 | GO:0032689 | Not Cancer Driver | No | 28 | 0.1106719367588932 | 117 | 8 | 0.0316205533596837 | 19 |
RARA-201 | RARA | P10276 | Retinoic acid receptor alpha | chr17 | GO:0032689 | Census, Compendium | Yes | 60 | 0.1298701298701298 | 167 | 14 | 0.0303030303030303 | 0 |
SCGB1A1-201 | SCGB1A1 | P11684 | Uteroglobin | chr11 | GO:0032689 | Not Cancer Driver | No | 7 | 0.0769230769230769 | 14 | 1 | 0.0109890109890109 | 0 |
SLAMF1-201 | SLAMF1 | Q13291 | Signaling lymphocytic activation molecule | chr1 | GO:0032689 | Not Cancer Driver | No | 54 | 0.1611940298507462 | 64 | 8 | 0.0238805970149253 | 0 |
TLR4-201 | TLR4 | O00206 | Toll-like receptor 4 | chr9 | GO:0032689 | Not Cancer Driver | No | 253 | 0.301549463647199 | 0 | 0 | 0.0 | 0 |
TNFSF4-201 | TNFSF4 | P23510 | Tumor necrosis factor ligand superfamily member 4 | chr1 | GO:0032689 | Not Cancer Driver | No | 17 | 0.0928961748633879 | 1 | 0 | 0.0 | 0 |
VSIR-201 | VSIR | Q9H7M9 | V-type immunoglobulin domain-containing suppressor of T-cell activation | chr10 | GO:0032689 | Not Cancer Driver | No | 41 | 0.1318327974276527 | 135 | 15 | 0.0482315112540192 | 0 |
XCL1-201 | XCL1 | P47992 | Lymphotactin | chr1 | GO:0032689 | Not Cancer Driver | No | 25 | 0.219298245614035 | 35 | 10 | 0.087719298245614 | 0 |
ZC3H12A-201 | ZC3H12A | Q5D1E8 | Endoribonuclease ZC3H12A | chr1 | GO:0032689 | Not Cancer Driver | No | 77 | 0.1285475792988314 | 397 | 38 | 0.0634390651085141 | 0 |